Business
Bionano Genomics Announces American Society of Human Genetics Presentations Featuring Optical Genome Mapping for Genetic Disease and Cancer Research Applications
SAN DIEGO, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), developer of the Saphyr® system that uses optical genome mapping (OGM) for the
About this update from Bionano Genomics, Inc.
[{"type":"text","content":"SAN DIEGO, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), developer of the Saphyr® system that uses optical genome mapping (OGM) for the detection and analysis of structural variants (SVs), today announced the American Society of Human Genetics (ASHG) conference lineup of customer posters and presentations featuring OGM. The customer posters and presentations span genetic disease applications including amyotrophic lateral sclerosis (ALS) and postnatal, as well as cancer research applications including pediatric brain tumors and myelodysplastic syndromes (MDS). The ASHG conference is being held virtually this year and runs from Monday, October 18, 2021 to Friday, October 22, 2021. Talks featuring Bionano Genomics OGM solutions include research into how structural variation contributes to the cause of ALS; inverted genomic triplication structures; and a multi-site clinical validation study of constitutional postnatal SV, CNV and repeat array sizing, as well as findings of SVs in pediatric brain tumors, and epigenetics. Below is a list of customer presentations featuring OGM at this year’s ASHG conference. OGM Application AreaPresenterAffiliationPresentation Title Inherited Genetic DisordersDr. C.M. GrochowskiBaylor College of MedicineInverted genomic triplication structures: two breakpoint junctions, several possibilities Dr. Emily McCannMacquarie Univ. Ctr. for MND Research, Sydney, AustraliaDevelopment of a discovery pipeline for structural variation contributing to the cause of amyotrophic lateral sclerosis Dr. Nikhil SahajpalAgusta University, Praxisgenomics, University of Iowa HospitalOptical Genome Mapping for Constitutional Postnatal SV, CNV, and Repeat Array Sizing: A Multisite Clinical Validation Study Dr. Ravindra KolheAugusta UniversityLarge-Scale, Multi-site, Postnatal Studies on Optical Genome Mapping (OGM) Hematological MalignanciesDr. Rashmi Kanagal-ShamannaMD Anderson Cancer CenterOptical Genome Mapping Improves the Clinically Relevant Structural Variant Detection in MDS Dr. Gordana RacaChildren's Hospital Los AngelesUtilization of Optical Genome Mapping in Detection and Characterization of Rare Genetic Markers in Pediatric Leukemias Solid Tumor AnalysisDr. Miriam BornhorstChildren’s National HospitalOptical genome mapping reveals novel structural variants in pediatric brain tumors Epigenetics App...